Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Muscle Invasive Bladder Cancer × danvatirsen × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2 Muscle Invasive Bladder Cancer 1 Lymphoma, Non-Hodgkin 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumours 1 Advanced Solid Malignancies 1

Interventions

vistusertib 1 tislelizumab 1 olaparib 1 durvalumab 1 danvatirsen 1 adavosertib 1 Rutin 1 Gemcitabine 1 Cisplatin 1 AZD4547 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02546661 2025-12-29

BISCAY

AstraZeneca

Phase 1 Active not recruiting

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡